Central Bank & Trust CO Eli Lilly & CO Transaction History

Central Bank & Trust CO

$718 Million
Q2 2024

A detailed history of Central Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Central Bank & Trust CO holds 2,552 shares of LLY stock, worth $2.35 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

2,552

Previous 2,880 11.39%

Holding current value

$2.35 Million

Previous $2.24 Million 3.13%

% of portfolio

0.32%

Previous 0.32%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $237,757 - $298,165	-328 Reduced 11.39%	2,552 $2.31 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $132,652 - $177,470	-224 Reduced 7.22%	2,880 $2.24 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $156,506 - $184,500	-298 Reduced 8.76%	3,104 $1.81 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $5,651 - $7,790	-13 Reduced 0.38%	3,402 $1.83 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $27,357 - $36,580	-78 Reduced 2.23%	3,415 $1.6 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $95,363 - $111,999	-307 Reduced 8.08%	3,493 $1.2 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $9,003 - $10,490	28 Added 0.74%	3,800 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $136,973 - $156,095	462 Added 13.96%	3,772 $1.22 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $168,631 - $197,998	605 Added 22.37%	3,310 $1.07 Million
Q1 2022 Apr 18, 2022	BUY	$234.69 - $291.66 $43,652 - $54,248	186 Added 7.38%	2,705 $775,000
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $22,485 - $27,904	-100 Reduced 3.82%	2,519 $696,000
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $29,029 - $35,725	-131 Reduced 4.76%	2,619 $605,000
Q2 2021 Jul 16, 2021	SELL	$180.55 - $233.54 $33,943 - $43,905	-188 Reduced 6.4%	2,750 $631,000
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $4,108 - $5,318	-25 Reduced 0.84%	2,938 $549,000
Q4 2020 Jan 12, 2021	BUY	$130.46 - $172.63 $102,932 - $136,205	789 Added 36.29%	2,963 $500,000
Q3 2020 Oct 08, 2020	BUY	$146.22 - $169.13 $27,050 - $31,289	185 Added 9.3%	2,174 $322,000
Q2 2020 Jul 15, 2020	BUY	$136.42 - $164.18 $115,684 - $139,224	848 Added 74.32%	1,989 $327,000
Q1 2020 Apr 14, 2020	SELL	$119.05 - $147.35 $5,357 - $6,630	-45 Reduced 3.94%	1,096 $152,000
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $5,357 - $6,630	45 Added 4.11%	1,141 $126,000
Q2 2019 Jul 16, 2019	SELL	$110.79 - $129.32 $14,402 - $16,811	-130 Reduced 10.23%	1,141 $126,000
Q1 2019 Apr 22, 2019	BUY	$111.31 - $131.02 $6,789 - $7,992	61 Added 5.04%	1,271 $165,000
Q2 2018 Jul 17, 2018	SELL	$75.7 - $86.88 $4,466 - $5,125	-59 Reduced 4.65%	1,210 $103,000
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $97,801 - $108,550	1,269	1,269 $109,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $876B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account

Central Bank & Trust CO Eli Lilly & CO Transaction History